G P Vlasuk - Concepedia

Author

G P Vlasuk

Also Known As

G P Vlasuk, G Vlasuk, G. P Vlasuk, G. P. Vlasuk, G. Vlasuk, G.P. VLASUK, G.P. Vlasuk, George P. Vlasuk, Geroeg P. Vlasuk, James L. Ellis

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)Cancer Institute (WIA)Stony Brook University Women's Health Research Institute

About

G P Vlasuk is an author at United States Military Academy specializing in medicine, pharmacology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1.6K
2	Natural Sciences	6	6	231
3	Biochemistry	6	6	193
4	Health Sciences	4	4	399
5	Allergy	4	4	926

G P Vlasuk

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Tick Anticoagulant Peptide (TAP) Is a Novel Inhibitor of Blood Coagulation Factor Xa Lloyd Waxman, Donna Smith, Karen E. Arcuri, Science Tick Anticoagulant PeptideNovel InhibitorAntiparasitic AgentImmunologyPathology	1990	413
Anticoagulant repertoire of the hookworm Ancylostoma caninum. P. Stassens, Peter W. Bergum, Yannick Gansemans, Proceedings of the National Academy of Sciences Hematophagous NematodesParasitic DiseaseAllergyBinary ComplexParasitic Protozoa	1996	260
Effects of the complete removal of basic amino acid residues from the signal peptide on secretion of lipoprotein in Escherichia coli. G P Vlasuk, S Inouye, Hirataka Ito, Journal of Biological Chemistry	1983	216
Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. Michael Cappello, G P Vlasuk, Peter W. Bergum, Proceedings of the National Academy of Sciences ImmunohematologyHuman CoagulationImmunologyPathologyBlood Loss	1995	174
Phenobarbital induction of rat liver cytochromes P-450b and P-450e. Quantitation of specific RNAs by hybridization to synthetic oligodeoxyribonucleotide probes. Curtis J. Omiecinski, F G Walz, G P Vlasuk Journal of Biological Chemistry	1985	132
Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis. Gary R. Sitko, Denise Ramjit, Inez I. Stabilito, Circulation	1992	131
Identification of atrial natriuretic factor gene transcripts in the central nervous system of the rat. David G. Gardner, G P Vlasuk, John D. Baxter, Proceedings of the National Academy of Sciences GeneticsTranscriptional RegulationAnf PeptidesGene StructureRna Processing	1987	119
Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Michael Ragosta, Lawrence W. Gimple, S. David Gertz, Circulation	1994	113
Characterization of recombinant tick anticoagulant peptide. A highly selective inhibitor of blood coagulation factor Xa. Michael P. Neeper, Lloyd Waxman, Donna Smith, Journal of Biological Chemistry Tick Anticoagulant PeptideProtein SecretionImmunologyMolecular BiologyThrombosis	1990	105
Antithrombotic efficacy of recombinant tick anticoagulant peptide. A potent inhibitor of coagulation factor Xa in a primate model of arterial thrombosis. L W Schaffer, J T Davidson, G P Vlasuk, Circulation	1991	81

Page 1